Acetyl Hexapeptide-39 Silusyne Slimming Peptide Powder

  • Product Name: Acetyl Hexapeptide-39 / Silusyne
  • Function: Slimming
  • Specification: 1Gram/ Bottle, 1Kg/Foil bag, 25Kg/Drum
  • Trademark: New Peptide

Note: Due to policy changes, some products have not been disclosed on here, you can visit www.goodpeptides.com.

If you couldn't find the product you want, please feel free to contact us through mail: sales@npeptides.com or whatsapp +86 18073326374; if you want to customize and process the product you want, please feel free to contact us for more details too.

Acetyl Hexapeptide-39 Silusyne reduces peroxisome proliferator-activated receptor Gamma coactivator 1a(PGC-1a) activity and decreases adipogenesis. It is used as a slimming agent. Acetyl Hexapeptide-39 (slimming peptide) is a new weight loss and slimming active peptide containing six amino acids, which has the effect of reducing cellulite, cellulite, cellulite and slimming.


Item

Value

Place of Origin

China

 CAS No


Product Name

Acetyl Hexapeptide-39 / Silusyne

Brand

New Peptide

Appearance

white powder

Usage

Cosmetic 

Application

Chemical Intermediates

MOQ

1gram

Package

1Gram/ Bottle,1Kg/Foil bag,25Kg/Drum

Shelf Life

2 Years Proper Storage

Storage

This product should be sealed and shaded and stored in a dry

undefined


undefinedundefined


undefinedundefined


undefined

 

undefined

undefined

undefinedundefinedundefined

SEND US MAIL
Please message and we will get back to you!
RELATED PRODUCTS
Wet diamond polishing pads for granite 2mg

2mg

is FDA approved for weight loss.
Wet diamond polishing pads for granite Tirzepatide 5mg

Tirzepatide 5mg

Tirzepatide, brand name Mounjaro, is used for the treatment of type 2 diabetes.
Wet diamond polishing pads for granite Retatrutide  5mg

Retatrutide 5mg

Retatrutide (LY-3437943) is an experimental drug for obesity . It is a triple hormone receptor agonist of GLP-1, GIP, and GCGR receptors. It has been shown to achieve a more than 24% mean weight reduction in non-diabetic obese or overweight adults during a phase 2 trial.
Copyright © Zhuzhou New Peptides Tech Co., Ltd. / sitemap / XML / Privacy Policy   

Home

PRODUCTS

About Us

Contact